Ai Li

247 Beiyuan Road
Jinan, 250033, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

IL-1Ra overexpression enhances the therapeutic efficacy of mesenchymal stem cells in acute lung injury.

IL-1Ra overexpression enhances the therapeutic efficacy of mesenchymal stem cells in acute lung injury.

Journal: International immunopharmacology

Published: April 27, 2026

Therapeutic outcomes of TP53-mutated diffuse large B cell lymphoma: A systematic review and meta-analysis.

Therapeutic outcomes of TP53-mutated diffuse large B cell lymphoma: A systematic review and meta-analysis.

Journal: iScience

Published: March 10, 2026

DKC1: a robust prognostic factor and potential therapeutic target in multiple myeloma.

DKC1: a robust prognostic factor and potential therapeutic target in multiple myeloma.

Journal: Journal of translational medicine

Published: November 13, 2025

Macrophage ferroptosis in hematologic malignancies: emerging mechanisms and therapeutic implications.

Macrophage ferroptosis in hematologic malignancies: emerging mechanisms and therapeutic implications.

Journal: Apoptosis : an international journal on programmed cell death

Published: October 25, 2025

Neurological graft-versus-host disease with MOG antibody positivity after allogeneic stem cell transplantation: a case report.

Neurological graft-versus-host disease with MOG antibody positivity after allogeneic stem cell transplantation: a case report.

Journal: Frontiers in immunology

Published: August 13, 2025

Expression profiling reveals coordinated dysregulation of autophagy-associated proteins in marginal zone lymphoma and therapeutic implications.

Expression profiling reveals coordinated dysregulation of autophagy-associated proteins in marginal zone lymphoma and therapeutic implications.

Journal: Oncology letters

Published: July 10, 2025

Correction: Interleukin-1 receptor antagonist overexpression in mesenchymal stem cells improves hemorrhagic cystitis outcomes via HtrA serine peptidase 3.

Correction: Interleukin-1 receptor antagonist overexpression in mesenchymal stem cells improves hemorrhagic cystitis outcomes via HtrA serine peptidase 3.

Journal: Stem cell research & therapy

Published: July 07, 2025

Interleukin-1 receptor antagonist overexpression in mesenchymal stem cells improves hemorrhagic cystitis outcomes via HtrA serine peptidase 3.

Interleukin-1 receptor antagonist overexpression in mesenchymal stem cells improves hemorrhagic cystitis outcomes via HtrA serine peptidase 3.

Journal: Stem cell research & therapy

Published: February 05, 2025

Lactate dehydrogenase A is implicated in the pathogenesis of B-cell lymphoma through regulation of the FER signaling pathway.

Lactate dehydrogenase A is implicated in the pathogenesis of B-cell lymphoma through regulation of the FER signaling pathway.

Journal: BioFactors (Oxford, England)

Published: December 03, 2023

Efficacy and safety of umbilical cord mesenchymal stem cells for the treatment of patients with COVID-19.

Efficacy and safety of umbilical cord mesenchymal stem cells for the treatment of patients with COVID-19.

Journal: Clinics (Sao Paulo, Brazil)

Published: November 30, 2020

Novel Small Molecular Compound AE-848 Potently Induces Human Multiple Myeloma Cell Apoptosis by Modulating the NF-κB and PI3K/Akt/mTOR Signaling Pathways.

Novel Small Molecular Compound AE-848 Potently Induces Human Multiple Myeloma Cell Apoptosis by Modulating the NF-κB and PI3K/Akt/mTOR Signaling Pathways.

Journal: OncoTargets and therapy

Published: July 07, 2020

Baseline characteristics and changes of biomarkers in disease course predict prognosis of patients with COVID-19.

Baseline characteristics and changes of biomarkers in disease course predict prognosis of patients with COVID-19.

Journal: Internal and emergency medicine

Published: May 13, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026